Merdad Parsey - 10 Nov 2021 Form 4 Insider Report for GILEAD SCIENCES INC (GILD)

Role: Chief Medical Officer
Signature: /s/ Amy Kim by Power of Attorney for Merdad Parsey
Issuer symbol: GILD
Transactions as of: 10 Nov 2021
Net transactions value: -$156,182
Form type: 4
Filing time: 12 Nov 2021, 17:01:20 UTC
Previous filing: 24 Aug 2021
Next filing: 28 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+5,100	+36%		19,180	10 Nov 2021	Direct	F1
transaction	GILD	Common Stock	Tax liability	$156,182	-2,320	-12%	$67.32	16,860	10 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-5,100	-14%		32,089	10 Nov 2021	Common Stock	5,100		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.